What is LBTSF stock price today?

LBTSF (Almirall S.A) stock is trading at $15.35 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is LBTSF stock going up or down today?

LBTSF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy LBTSF stock now?

The decision to buy LBTSF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is LBTSF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for LBTSF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is LBTSF stock overvalued or undervalued?

LBTSF currently trades at a P/E ratio of 59.04, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if LBTSF is fairly priced.

What is LBTSF's P/E ratio?

LBTSF has a price-to-earnings (P/E) ratio of 59.04, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is LBTSF's market cap?

LBTSF (Almirall S.A) has a market capitalization of $3.29 billion, making it a small-cap stock.

What is LBTSF's price to book ratio?

LBTSF trades at a price-to-book (P/B) ratio of 1.89, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does LBTSF pay dividends?

Yes, LBTSF pays dividends with a current yield of 0.02%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is LBTSF's dividend yield?

LBTSF's dividend yield is 0.02%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is LBTSF stock a good long-term investment?

LBTSF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is LBTSF's revenue growth rate?

LBTSF has shown revenue growth of 0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, LBTSF is profitable with a profit margin of 0.0%. This indicates the company generates 0.0 cents of profit for every dollar of revenue.

What are the risks of investing in LBTSF?

Key risks for LBTSF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does LBTSF compare to its competitors?

Compare LBTSF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize LBTSF's performance and positioning.

What is LBTSF's stock price target for 2026?

Our AI model provides price targets for LBTSF based on fundamental analysis: Bull case $19.96 (+30%), Base case $17.65 (+15%), Bear case $13.81 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about LBTSF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for LBTSF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is LBTSF's next earnings report?

LBTSF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

LBTSF - Almirall S.A

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$15.35

+$0.00 (+0.00%)

About Almirall S.A

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism, anti-infective for systemic use, cardiovascular system, dermatological, genito urinary system and sex hormones, immunostimulants, metabolism, musculo-skeletal system, nervous system, respiratory system, systemic hormonal preparations. It also develops tirbanibulin for actinic keratosis, and tildrakizumab for psoriatic arthritis under the registration phase, as well as lebrikizumab for atopic dermatitis pediatric in phase 2; Anti-IL-1RAP mAb for hidradenitis suppurativa, anti-IL-1RAP mAb for inflammatory skin disease, Anti-IL-21 mAb for hidradenitis suppurativa, IL-2muFc for alopecia areata, IL-2muFc for atopic dermatitis, and IL-2muFc for inflammatory skin disease in phase 2; readthrough inducer for rare dermatology in phase 1; and anti-IL-13/OX40L BsAb for atopic dermatitis, SMOL oral for Th2-driven diseases, and mRNA/LNP for non-melanoma skin cancer in preclinical stage. It has research and development agreements with Evotec, Ichnos, Simcere, Etherna, Novo Nordisk, and Eloxx. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

LBTSF Key Statistics

Market Cap

$3.29B

P/E Ratio

59.04

P/B Ratio

1.89

EPS

$0.26

Dividend Yield

0.02%

Revenue Growth

+0.1%

Profit Margin

0.0%

Employees

2,108

How LBTSF Compares to Peers

LBTSF ranks 2nd in revenue growth vs peers

LBTSF is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
LBTSF(This stock)	$3.29B	59.0	0%	0.0%	-
LLYEli Lilly	$809.09B	39.3	0%	0.3%	vs LLY
JNJJohnson &	$565.22B	21.3	0%	0.2%	vs JNJ
PFEPfizer Inc	$154.84B	20.0	-0%	0.1%	vs PFE
MRKMerck &	$285.46B	15.8	0%	0.3%	vs MRK
ABBVAbbvie Inc	$369.65B	88.6	0%	0.1%	vs ABBV

Almirall S.A Company Information

Headquarters: Ronda General Mitre, 151, Barcelona, Spain, 08022, undefined
Website: www.almirall.com
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

About Almirall S.A

LBTSF Key Statistics

How LBTSF Compares to Peers

Almirall S.A Company Information

Upcoming Events for LBTSF